Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Post by RedDeerMoneymanon Sep 05, 2015 11:18pm
193 Views
Post# 24082078

HEY SHORTS

HEY SHORTS If the day traders would have a reality check at what this stock is really worth and stop day trading for a few hundred bucks of profit. We could all be making thousands. 
There is three weeks till the 4 for 1 vote and obviously management is frustrated at all the positive news they have released this past year, which in turn should have this SP well over the 20 cent mark.
If the vote is passed and we all loose 75% of our volumes. You can guarantee were all going to loose a lot more after the price increase because of all the cheap warrants. Which will then again drop the share price.
So just to throw this out there quite giving away these damn shares and look forward to a SP like Zynerba at $30.00, which inmed is further ahead in both people and science.
I have personal thoughts on where this company is going and am looking forward to the big payday with my current volume. You should all too.

Cheers to all who have invested in Inmed like myself.
Bullboard Posts